Clinical Trial Details
EORTC-30072
Back to Clinical Trials Database
A Phase III Randomised Double-blind Study Comparing Sorafenib With Placebo In Patients With Resected Primary Renal Cell Carcinoma at High or Intermediate Risk of Relapse
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 23-Mar-2009 Date Step1 close: 12-Apr-2013 |
Data management at EORTC | No |
Design |
Phase 3 Randomized blind |
Targeted Sample size | EORTC Groups: 200 - All Groups: 1656 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00492258 |
NCT number | NCT00492258 |
EudraCT | 2006-006079-19 |